Image

Rheumatology Patient Registry and Biorepository

Rheumatology Patient Registry and Biorepository

Recruiting
18-99 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

A rheumatology biorepository will be created to permit comparative analyses between the rheumatic diseases in order to increase the understanding of disease pathogenesis. Patients diagnosed with rheumatic diseases are invited to participate in this study. These rheumatic diseases include, but are not limited to: adult onset Still's disease, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, antiphospholipid syndrome, systemic lupus erythematosus, Behcet's disease, dermatomyositis, polymyositis, giant cell arteritis and other vasculitides, Lyme's disease, mixed connective tissue disease, polymyalgia rheumatica, rheumatoid arthritis, sarcoidosis, systemic sclerosis (scleroderma), Sjogren's syndrome, and undifferentiated connective tissue disease. Healthy volunteers are also invited to participate in this study.

Print
Study details
    Dermatomyositis
    Rheumatism
    Ankylosing spondylitis
    Ankylosing spondylitis
    Psoriasis
    Antiphospholipid Syndrome
    Antiphospholipid Syndrome
    Behcet's Syndrome
    Adult Onset Still's Disease
    CONNECTIVE TISSUE DISEASE
    dermatomyositis (connective tissue disease)
    Sicca Syndrome
    Reiter's syndrome
    Reiter's syndrome
    PSORIATIC ARTHRITIS
    PSORIATIC ARTHRITIS
    Lyme Disease
    Lyme Disease
    Giant Cell Arteritis
    Rheumatoid Arthritis
    Rheumatoid Arthritis
    Scleroderma
    Systemic sclerosis
    Scleroderma
    Anterior uveitis
    Anterior uveitis
    Polymyalgia Rheumatica
    Myositis
    Myositis
    Dermatosis
    SYSTEMIC LUPUS ERYTHEMATOSUS
    SYSTEMIC LUPUS ERYTHEMATOSUS
    Lyme Disease Vaccine
    Musculoskeletal Disease
    Lymphoproliferative Disorder
    Mixed Connective Tissue Disease
    Sarcoidosis
    Sarcoidosis
    Arthritis
    Polymyositis
    dermatomyositis (connective tissue disease)

NCT04402086

Yale University

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.